Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.


  1. Home


  2. Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.


  3. Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.

Agapova M, Duignan A, Smith A, O’Neill C, Basu A. Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland. Expert Rev Pharmacoecon Outcomes Res. 2015 Dec;15(6):999-1005. doi: 10.1586/14737167.201

Upcoming Events

Full Calendar


News Categories